We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Breakthrough Shows Neuropilin-1 Drives SARS-CoV-2 Infectivity

News   Oct 20, 2020 | Original story from the University of Bristol

 
Breakthrough Shows Neuropilin-1 Drives SARS-CoV-2 Infectivity

Neuropilin-1 (NRP1) is a host factor for SARS-CoV-2 infection. The image shows human cells infected with SARS-CoV-2 and expressing viral proteins (shown in green). Removal of NRP1 from cells or treating cells with a drug or an antibody targeting NRP1 reduces SARS-CoV-2 infection. Credit: The University of Bristol.

 
 
Advertisement
 

RELATED ARTICLES

Key Questions and Answers About the UK's First Approved COVID-19 Vaccine

News

The UK government has announced that the COVID-19 vaccine BNT162b2 – developed by Pfizer and BioNTech – has been authorized for use. Here, we address some of the key questions you may have about this announcement.

READ MORE

New Lab-on-Chip Infection Test Could Enable Cheaper, Faster Portable Diagnostics

News

A tiny new silicon-based lab-on-chip test could pave the way for cheap handheld infectious disease testing. The chip, developed at Imperial College London and known as TriSilix, is a ‘micro laboratory’ which performs a miniature version of the polymerase chain reaction (PCR) on the spot.

READ MORE

"Perturb-Seq" Unravels Function of Autism Genes

News

New technology has been designed that can determine the function of different genes in different cells simultaneously. They look specifically at those involved in autism.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE